TNFSF10 and glioblastoma: A recent study also reveals that TRAIL sensitivity in GBM cells can be enhanced by conjugation of TRAIL with silver nanoparticles, further supporting nanoparticle delivery to be a promising therapeutic approach to bypass consumption of TRAIL in circulation and effectively increase the TRAIL dose in tumor lesions for sensitizing TRAIL resistance [112].